Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from 4DMedical Ltd ( (AU:4DX) ) is now available.
4DMedical Ltd announced a change in Director Andreas Fouras’ interests in securities, which involved the acquisition of 4,568,275 unlisted options through an options grant approved at the Annual General Meeting. This move reflects a strategic alignment between leadership incentives and the company’s growth objectives, highlighting confidence in the firm’s market positioning and trajectory.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd operates in the healthcare technology sector, focusing on innovative medical imaging solutions. The company specializes in developing and delivering advanced lung imaging technology systems aimed at revolutionizing respiratory diagnostics and enhancing patient care.
Average Trading Volume: 5,143,817
Technical Sentiment Signal: Buy
Current Market Cap: A$1.55B
See more insights into 4DX stock on TipRanks’ Stock Analysis page.